SOUTH KOREA · OPENDART
NEXTBIOMEDICAL Co., Ltd.
넥스트바이오메디컬 · 389650 · KOSDAQ · Healthcare · Biotechnology
Score
56.4
Insider timeline
2 insiders bought within 7 days, 16 Jun to 22 Jun: 1 Executive, 1 Board member. The share closed at 42,000.00 on the first of those days and at 26,350.00 most recently (−37.3%).
Tap an item for what it means.
●A purchase: the bigger the dot, the more was bought
Each dot is one insider's purchases on one day. The dot's area follows the amount: the largest purchase here gets the largest dot. Hold the pointer over a dot to see the date and the amount.
▮Purple band: several insiders bought within 15 days
The band marks the stretch with the most different buyers: at most 15 days long and at least two people. Here it is 16 Jun – 22 Jun, with 2 insiders. Only the strongest stretch is marked. Several people deciding the same thing is harder to explain by one person's private reasons, but insiders often buy together just after a closed period ends, so compare it with the grey weekly bars.
Blue line: this share's price, −57.4% over these six months
The closing price of each day, from 61,800.00 on 2026-04-21 to 26,350.00 on 2026-10-16. The line has no scale; read it for high and low: a dot on a low stretch was bought cheaply, a dot on a high stretch was not.
Dashed line: the typical stock on the same exchange, −31.9%
Taken from the 1525 other stocks on the same exchange that this site holds prices for. Each is measured from the first day of the window, and every day the middle one is drawn. It starts where the blue line starts, so the gap between the two is the difference: this share −57.4%, the typical one −31.9%, 25.5 points behind. It is not an index and not a comparison within one industry.
This company: insiders buying per month, last 12 months
Darker bars are inside the 180-day window above.
Who traded
| Insider | Role | Purchases | Sales | Bought | First purchase | Share price since |
|---|---|---|---|---|---|---|
| Kang Cheol-jung | Executive | 1 | — | 81.3M KRW | 2026-06-16 | −37.3% |
| Nam Dong-heun | Board member | 1 | — | 39.2M KRW | 2026-06-22 | −34.6% |
Insiders' buying price vs the latest close
Insiders paid 40,166.67 KRW a share on average (2 purchase lines, 2 buyers, 2026-06-16 – 2026-06-22). The close on 2026-10-16 was 34.4% below that price.
The latest purchase (2026-06-22) was at 39,200.00 KRW; the close was 32.8% below that price.
Prices paid are weighted by shares and taken from the filings; dividends are not counted. Not scored.
Insider trades on the exchange
Purchases and sales on the exchange in the last 12 months. The filing gives the settlement date; the trade date is two trading days earlier.
| Trade date | Insider | Role | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-22 | Nam Dong-heun | Director | Bought on the exchange | 1,000 | ₩39,200 | ₩39.2M | DART ↗ |
| 2026-06-16 | Kang Cheol-jung | Senior managing director | Bought on the exchange | 2,000 | ₩40,650 | ₩81.3M | DART ↗ |
| 2025-11-27 | Lee Eun-hye | Managing director | Sold on the exchange | 1,074 | ₩83,000 | ₩89.1M | DART ↗ |
| 2025-10-22 | Lee Eun-hye | Managing director | Sold on the exchange | 9,400 | ₩65,000 | ₩611.0M | DART ↗ |
Other changes in holdings · 4
Option exercises, grants, new shares, inheritance, gifts, off-exchange trades and trades by companies and funds. Not counted in the score.